|
|
|
|
|
by jjulius
1315 days ago
|
|
>Is the fake accounts thing overblown? From the article: >By Friday morning, Lilly stock had dropped by more than 5% from the day before. The Twitter stunt pulled down the stock price of other diabetes drugmakers, including Novo Nordisk and Sanofi. Lilly’s stock has yet to recover and, on Monday morning, remained down more than 4% over the past five days. I'm not normally one to defend drug makers, but when you're talking about the loss of ~$15 billion in market cap[1], and then you factor in the fact that the company themselves was so frustrated by this that they walked away from their ad deal with Twitter, it all makes it hard for me to see how this is "overblown". [1]https://gizmodo.com/twitter-eli-lilly-elon-musk-insulin-1849... |
|
It seems much, much more likely the stock loss was part of a larger market event than a specific Twitter stunt.